Blue March: Raising Awareness and Improving Outcomes in Colorectal Cancer

Every March, the Blue March campaign focuses attention on colorectal cancer, a disease that presents a paradox: it’s one of the deadliest cancers, yet also one of the most curable – provided it’s detected early. Despite this, screening rates remain suboptimal, leaving many vulnerable to late-stage diagnoses and poorer outcomes.

Understanding Colorectal Cancer

Colorectal cancer is a cancer that starts in the colon or rectum. According to the Pierre Fabre Foundation, approximately 1.9 million cases are diagnosed annually worldwide, with around 520,000 in Europe [1]. It is the third most common cancer globally and the second leading cause of cancer death [1]. In France, it affects roughly the same number of men and women, with over 43,000 new cases and 17,000 deaths reported in 2018 [2].

The Importance of Screening

Early detection is crucial for successful treatment. Nine out of ten individuals diagnosed with early-stage colorectal cancer can be cured [2]. However, screening rates are concerningly low. Less than 30% of the at-risk population in France undergoes regular screening [2], a figure that has been declining for five years.

France’s National Screening Program

France has a national colorectal cancer screening program available for individuals aged 50 to 74. Participants receive a letter from Health Insurance outlining the process. Screening involves an immunoassay, a test that can detect abnormalities before symptoms appear [1]. This test is recommended every two years.

How the Screening Test Works

The screening test can be completed at home. Individuals can check their eligibility with their doctor or pharmacist, or through an online self-questionnaire. The screening kit can be obtained from a pharmacy or ordered online through the Health Insurance and National Cancer Institute website [1]. The test is painless, quick, and involves collecting a stool sample.

Addressing Barriers to Screening

The “Bougez-vous le côlon” (Move Your Colon) campaign aims to overcome the barriers that prevent people from getting screened, such as embarrassment or lack of awareness [1]. Participation in France remains lower than the European average of 45%, with some regions, like Provence-Alpes-Côte d’Azur, experiencing even lower rates [1].

The Role of Health Insurance and League Against Cancer

Health Insurance and the League Against Cancer are partnering in the Mars Bleu awareness campaign to promote colorectal cancer screening [1]. This collaboration underscores the importance of a public health approach to tackling this preventable disease.

Key Takeaways

• Colorectal cancer is a major public health concern, but early detection significantly improves outcomes.
• France has a national screening program for individuals aged 50-74.
• The screening test is simple, painless, and can be done at home.
• Increasing screening rates is crucial to reducing the burden of colorectal cancer.